Literature DB >> 24378522

NASPGHAN single-topic symposium: discovering the future of pediatric IBD care.

Wallace V Crandall1, Robert Baldassano, Athos Bousvaros, Lee A Denson, Neera Gupta, Laura M Mackner.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24378522      PMCID: PMC3889135          DOI: 10.1097/MPG.0000000000000178

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  65 in total

1.  Individually tailored treatment of medication nonadherence.

Authors:  Kevin A Hommel; Michele Herzer; Lisa M Ingerski; Elizabeth Hente; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

Review 2.  Review: psychosocial issues in pediatric inflammatory bowel disease.

Authors:  Laura M Mackner; Dory P Sisson; Wallace V Crandall
Journal:  J Pediatr Psychol       Date:  2004-06

Review 3.  Systematic review: has disease outcome in Crohn's disease changed during the last four decades?

Authors:  F L Wolters; M G V M Russel; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

4.  Risk factors for initial surgery in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Stanley A Cohen; Alan G Bostrom; Barbara S Kirschner; Robert N Baldassano; Harland S Winter; George D Ferry; Terry Smith; Oren Abramson; Benjamin D Gold; Melvin B Heyman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.

Authors:  Osvaldo Borrelli; Letizia Cordischi; Manuela Cirulli; Massimiliano Paganelli; Valeria Labalestra; Stefania Uccini; Paolo M Russo; Salvatore Cucchiara
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

6.  Factors influencing postoperative recurrence of Crohn's disease in childhood.

Authors:  A M Griffiths; D E Wesson; B Shandling; M Corey; P M Sherman
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

7.  Challenges in pediatric inflammatory bowel disease.

Authors:  Athos Bousvaros; Francisco Sylvester; Subra Kugathasan; Eva Szigethy; Claudio Fiocchi; Richard Colletti; Anthony Otley; Devendra Amre; George Ferry; Steven J Czinn; Judy B Splawski; Maria Oliva-Hemker; Jeffrey S Hyams; William A Faubion; Barbara S Kirschner; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2006-09       Impact factor: 5.325

8.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

9.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

Authors:  Nicolas Barnich; Frédéric A Carvalho; Anne-Lise Glasser; Claude Darcha; Peter Jantscheff; Matthieu Allez; Harald Peeters; Gilles Bommelaer; Pierre Desreumaux; Jean-Frédéric Colombel; Arlette Darfeuille-Michaud
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

10.  Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.

Authors:  Eliseo Papa; Michael Docktor; Christopher Smillie; Sarah Weber; Sarah P Preheim; Dirk Gevers; Georgia Giannoukos; Dawn Ciulla; Diana Tabbaa; Jay Ingram; David B Schauer; Doyle V Ward; Joshua R Korzenik; Ramnik J Xavier; Athos Bousvaros; Eric J Alm
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more
  1 in total

Review 1.  Treat-to-target in Crohn's disease: Will transmural healing become a therapeutic endpoint?

Authors:  Elena Daniela Serban
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.